Targeting B7-H4: The Next Frontier in Immune Regulation
The therapeutic landscape encompasses diverse modalities including blocking antibodies, antibody-drug conjugates, bispecific platforms, and engineered T cell therapies, each addressing distinct aspects of B7-H4 biology and potentially serving separate market segments
